An 'AI scientist', working in collaboration with human scientists, has discovered that combinations of cheap and safe drugs could be effective at treating breast cancer.
Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
Tim Simpson, General Manager of Hologic UK & Ireland, discusses how AI, machine learning and prognostics could revolutionise cancer detection and treatment in breast and cervical cancer programmes.
Stefan Doroszkowski, Managing Director at Amethyst Radiotherapy Group UK, shares his stance on responding to the cancer care crisis, addressing the chasm in UK cancer care.
David Bloomfield, Consultant in Clinical Oncology Sussex Cancer Centre, argues that precision radiotherapy is our most effective cancer treatment and should be available to everyone with cancer, but workforce planning is failing our patients.
A meta-analysis finds that women who breastfeed are less likely to develop heart conditions or diseases, or die from cardiovascular disease than women who do not breastfeed.
Doctors now must take mandatory training on female-specific health, as a new women’s health strategy pushes for more equal research and medical conduct between...
Lester Litchfield, Data & Science Manager, Volpara Health, explores how to build confidence in the use of AI for mammography clinical practice
Artificial Intelligence (AI)...
Members of the Breast Cancer & Environment Research Program walk us through what we need to know about oestrogen signalling, including environmental chemicals & links with breast cancer.
